Karl Johe
Keine laufenden Positionen mehr
Profil
Karl Y.
Johe was the founder of Seneca Biopharma, Inc. which was founded in 1996, where he held the titles of Chairman & Chief Scientific Officer until 2016.
In 1993, he worked as a Staff Scientist-Molecular Biology Laboratory at the National Institute of Neurological Disorders & Stroke until 1997.
Dr. Johe's education history includes an undergraduate and graduate degree from the University of Kansas and a doctorate from Albert Einstein College of Medicine, Inc.
Ehemalige bekannte Positionen von Karl Johe
| Unternehmen | Position | Ende |
|---|---|---|
| National Institute of Neurological Disorders & Stroke | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1997 |
| PALISADE BIO, INC. | Gründer | - |
Ausbildung von Karl Johe
| University of Kansas | Graduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. | Health Technology |
| National Institute of Neurological Disorders & Stroke | Government |